Streetbeat News

ELV

Elevance Health Inc.

https://www.elevancehealth.com

Industry

Medical - Healthcare Plans

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Open

405.00

Mkt cap

93B

Volume

2.6M

High

408.58

P/E Ratio

14.58

52-wk high

567.26

Low

398.69

Div yield

0.02

52-wk low

397.98

Elevance Health reported its Q3 2024 financial results, with adjusted EPS of $8.37, missing the estimate of $9.66. However, the company exceeded sales expectations, reporting $44.719 billion compared to the estimated $43.330 billion.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 10:01 am

Elevance Health (NYSE:ELV) is set to release its quarterly earnings on October 17, 2024. Analysts expect an EPS of $9.66. The company's past performance shows mixed results, with a recent EPS beat leading to a share price drop. Analysts rate Elevance Health as 'Outperform' with a price target suggesting a 23.05% upside. The company faces challenges in revenue growth but excels in net margin and return on equity.

Portfolio Pulse from Benzinga Insights

October 16, 2024 | 2:01 pm

Elevance Health's shares fell by 3.8% following UnitedHealth Group's earnings report, which highlighted competitive pressures. UnitedHealth's strong performance and market share gains pose challenges for Elevance, impacting its stock. Both companies face rising medical costs and regulatory scrutiny.

Portfolio Pulse from Henry Khederian

October 15, 2024 | 4:07 pm

Elevance Health (NYSE:ELV) has significantly outperformed the market over the past decade, with an average annual return of 15.04%. A $1000 investment in ELV 10 years ago would now be worth $4,207.35, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 15, 2024 | 4:00 pm

UnitedHealth reported Q3 financial results and lowered the upper end of its annual EPS outlook, causing shares of health insurers to trade lower.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 1:18 pm

The article highlights significant options activity in the health care sector, focusing on various stocks with notable trades. It provides insights into the sentiment and potential market impact of these trades.

Portfolio Pulse from Benzinga Insights

October 07, 2024 | 5:35 pm

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Elevance Health (NYSE:ELV) and maintained a price target of $600.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 3:02 pm

Elevance Health (NYSE:ELV) has outperformed the market over the past 20 years with an average annual return of 13.33%, surpassing the market by 4.93% annually. A $1000 investment in ELV 20 years ago would be worth $12,132.03 today.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 4:00 pm

Elevance Health (NYSE:ELV) has seen significant options activity with a mix of bullish and bearish trades. The stock is currently trading at $534.89, down by 0.92%. Analysts have revised their ratings to 'Overweight' with price targets around $600-$615. The options activity suggests a targeted price range of $490 to $540.

Portfolio Pulse from Benzinga Insights

September 23, 2024 | 6:31 pm

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Elevance Health (NYSE:ELV) and maintained a price target of $600.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 2:55 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.